BardyDx: Hillrom loses Delaware court fight over Bardy Diagnostics acquisition; vows appeal
The Delaware Court of Chancery ordered Hillrom to proceed with its proposed acquisition of Bardy.
Read full article »
CEO
BardyDx develops and commercializes non-invasive ambulatory cardiac monitoring and arrhythmia detection devices for physicians.
Read more